Linkages of innate and adaptive immunity

Current Opinion in Immunology

Volumn 10, Issue 1, 1998, Pages 36-40

  Caroll, Michael C ^a   Prodeus, Andrey P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BACTERIAL ANTIGEN; BINDING PROTEIN; C REACTIVE PROTEIN; CD5 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR;

ADAPTATION; ANTIGEN BINDING; ANTIGEN RECOGNITION; B LYMPHOCYTE; COMPLEMENT ACTIVATION; ENDOTHELIUM CELL; GENE MUTATION; GERM LINE; IMMUNE SYSTEM; NONHUMAN; REVIEW; SOMATIC MUTATION;

EID: 0032006898     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80028-9     Document Type: Article

References (44)

1. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem. 57:1988;321-347.
2. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. of special interest Science. 272:1996;50-54 Review of the evidence supporting a critical role for innate immunity and in particular the complement system in enhancement of the adaptive immune response.
3. Epstein J, Eichbaum O, Sheriff S, Ezekowitz R. The collectins in innate immunity. of special interest Curr Opin Immunol. 8:1996;29-35 Review describing the importance of collectins as recognition molecules of natural immunity.
4. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res. 16:1997;127-136.
5. Reid KBM, Porter RR. The proteolytic activation systems of complement. Annu Rev Biochem. 50:1981;433-464.
6. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol. 13:1995;127-149.
7. Fischer M, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard R, Rothstein T, Kremmer E, Rosen F, Carroll M. Regulation of the B cell response to T-dependent antigens by classical pathway complement. of special interest J Immunol. 157:1996;549-556 First characterization of immune response of mice deficient in complement C3 or C4. Study demonstrated that the mice have an impaired primary and secondary immune response to T-cell-dependent antigens characterized by reduction in the number and size of germinal centers.
8. + B-1a cells. Deficient mice have impaired primary and secondary humoral response similar to that found for mice deficient in complement C3 or C4.
9. Croix D, Ahearn J, Rosengard A, Han S, Kelsoe G, Ma M, Carroll M. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. of outstanding interest J Exp Med. 183:1996;1857-1864 First report that B-cell expression of CD21/CD35 complement receptors is essential for humoral immune response.
10. Molina H, Holers V, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr R, Chaplin D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. of special interest Proc Natl Acad Sci USA. 93:1996;3357-3361 Describes impaired humoral response to T-cell dependent antigens in mice deficient in CD21 and CD35.
11. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. of special interest Science. 271:1996;348-350 Definitive experiments demonstrating that covalent attachment of C3d to soluble antigen significantly enhances its immunogenicity.
12. Kinoshita T, Lavoie S, Nussenzweig V. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II Identification and properties of complement receptor 1 (CR1). J Immunol. 134:1985;2564-2570.
13. Fingeroth JD, Benedict MA, Levy DN, Strominger JL. Identification of murine complement receptor type 2. Proc Natl Acad Sci USA. 86:1989;242-246.
14. Kurtz CB, O'Toole E, Christensen SM, Weis JH. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol. 144:1990;3581-3591.
15. Molina H, Kinoshita T, Inoue K, Carel J-C, Holers VM. A molecular and immunochemical characterization of mouse CR2. J Immunol. 145:1990;2974-2983.
16. Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine-kinase-dependent pathway that can be enhanced by the membrane IgM complex. J Immunol. 147:1991;3663-3671.
17. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TT. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol. 149:1992;2841-2850.
18. Kansas GS, Tedder TF. Transmembrane signals generated through MHC class II, CD19, CD20, CD39 and CD40 antigens induce LFA-1 dependent adhesion in human B cells through a tyrosine kinase-dependent pathway. J Immunol. 147:1991;4094-4102.
19. Carter RH, Fearon DT. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:1992;105-107.
20. Tedder TF, Zhou LJ, Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today. 15:1994;437-441.
21. Van Noesel CJM, Lankester AC, Van Lier RAW. Dual recognition by B cells. Immunol Today. 14:1993;8-11.
22. Tooze RM, Doody GM, Fearon DT. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. of special interest Immunity. 7:1997;59-67 Biochemical study of down stream signaling events mediated by coligation of CD19 and membrane immunoglobulin. Results demonstrate a synergistic effect in activation of MAP kinases Erk2, JNK and p38.
23. Engel P, Zhou LJ, Ord DC, Sata S, Koller B, Tedder TF. Abnormal B lymphocyte development activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50.
24. Rickert RC, Rajewsky R, Roes J. Impairment of T-cell dependent B cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
25. Kelsoe G. In situ studies of the germinal center reaction. Adv Immunol. 60:1995;267-288.
26. Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol. 10:1992;489-518.
27. Lavoie T, Drohan W, Smith-Gill S. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J Immunol. 148:1992;503-513.
28. Kelsoe G. The germinal center reaction. Immunol Today. 16:1995;324-326.
29. MacLennan I. Germinal Centers. Annu Rev Immunol. 12:1994;117-139.
30. Han S, Zheng B, Dal Porto J, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl. IV Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med. 182:1995;1635-1644.
31. Pulendran B, Kannaroukis G, Nouri S, Smith KGC, Nossal GJV. Soluble antigen can cause enhanced apoptosis of germinal-center B cells. Nature. 375:1995;331-334.
32. Shokat K, Goodnow C. Antigen-induced B-cell death and elimination during germinal centre immune response. Nature. 375:1995;334-338.
33. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR, Herzenberg LA. The ly-1 B lineage. Immunol Rev. 93:1986;81-102.
34. Herzenberg LA, Kantor AB. B cell lineages exist in the mouse. Immunol Today. 14:1993;79-83.
35. + B cells. Immunol Rev. 137:1994;91-118.
36. Krop I, DeFougerolles AR, Hardy RR, Allison M, Schlissel MS, Fearon DT. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur J Immunol. 26:1996;238-242.
37. Weiser D, Williams JP, Moore FD, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. of special interest J Exp Med. 183:1996;2343-2348 First report that ischemia-reperfusion injury is mediated by natural IgM.
38. + peritoneal B-1 cell.
39. Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD, Rosen FS, Carroll MC. Increased susceptibility to endotoxin shock in complement C3 and C4 deficient mice is corrected by C1 inhibitor replacement. of outstanding interest J Immunol. 159:1997;976-982 This report makes the novel observation that the classical pathway is critical in clearance of endotoxin. Moreover, failure to clear circulating endotoxin results in shock and death which can be reversed by treatment with C1 inhibitor.
40. Prodeus A, Zhou X, Maurer M, Galli S, Carroll MC. Impaired mast cell-dependent natural immunity to acute septic peritonitis in C3 deficient mice. of outstanding interest Nature. 390:1997;172-175 Demonstrates a definitive role for classical pathway complement in activation of peritoneal mast cells and host protection agains enteric bacterial infection.
41. Pennell CA, Arnold LW, Haughton G, Clarke SH. Restricted lg varible region gene expression among Ly-1 + B cell lymphomas. J Immunol. 141:1988;2788-2796.
42. +) B cells that recognize phosphatidyl choline. J Exp Med. 169:1989;1869-1877.
43. Malaviya R, Ikeda T, Ross E, Abraham N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α of outstanding interest Nature. 381:1996;77-80 This report demonstrates a critical role for peritoneal mast cells in host protection against bacterial infection and that protection is dependent on tumor necrosis factor-α
44. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. of outstanding interest Nature. 381:1996;75-77 This report makes the important observation that protection in the cecal ligation and puncture model of acute septic peritonitis is mast cell-dependent.